PRVB - Provention Bio - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

PRVB is currently covered by 5 analysts with an average price target of $6.01. This is a potential upside of $6.01 (0%) from yesterday's end of day stock price of $0.

Provention Bio's activity chart (see below) currently has 31 price targets and 28 ratings on display. The stock rating distribution of PRVB is 33.33% BUY and 66.67% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 47.08% with an average time for these price targets to be met of 230.09 days.

Highest price target for PRVB is $24, Lowest price target is $7, average price target is $6.01.

Most recent stock forecast was given by RAGHURAM SELVARAJU from HC WAINWRIGHT on 15-Mar-2023. First documented stock forecast 18-Jan-2019.

Currently out of the existing stock ratings of PRVB, 2 are a BUY (33.33%), 4 are a HOLD (66.67%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

$25

$0.02 (0.08%)

$16

1 years 9 months 2 days ago
(15-Mar-2023)

3/7 (42.86%)

$1.09 (4.56%)

138

Hold

$25

$0.02 (0.08%)

$22

1 years 9 months 3 days ago
(14-Mar-2023)

3/4 (75%)

$1.03 (4.30%)

124

Hold

$25

$0.02 (0.08%)

$30

1 years 9 months 3 days ago
(14-Mar-2023)

0/2 (0%)

$1.03 (4.30%)

Buy

$25

$0.02 (0.08%)

$30

1 years 9 months 4 days ago
(13-Mar-2023)

2/4 (50%)

$0.9 (3.73%)

175

Hold

$16

$-8.98 (-35.95%)

$12

1 years 9 months 4 days ago
(13-Mar-2023)

1/2 (50%)

$-8.1 (-33.61%)

255

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is PRVB (Provention Bio) average time for price targets to be met?

On average it took 230.09 days on average for the stock forecasts to be realized with a an average price target met ratio 47.08

Which analyst has the current highest performing score on PRVB (Provention Bio) with a proven track record?

GEULAH LIVSHITS

Which analyst has the most public recommendations on PRVB (Provention Bio)?

Geulah Livshits works at CHARDAN CAPITAL and has 9 price targets and 11 ratings on PRVB

Which analyst is the currently most bullish on PRVB (Provention Bio)?

Pasha Sarraf with highest potential upside - $10.02

Which analyst is the currently most reserved on PRVB (Provention Bio)?

Gregory Renza with lowest potential downside - -$14.98

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?